Ted W. Love, MD’s Post

Take a look at the replay of this important discussion about the dangers of tobacco use.

Multiple myeloma disproportionately impacts Black individuals, with higher diagnosis rates and delayed access to treatment. Despite this, Black patients are under-represented in multiple myeloma clinical trials. Diverse representation in research is a critical step to helping improve outcomes for all, and we must continue dialogue on how industry can better embed diversity, equity, and inclusion into clinical trials in multiple myeloma and beyond. I shared some of the ways Pfizer is working to increase diversity when designing, recruiting and implementing multiple myeloma clinical trials in a recent opinion article published in Clinical Leader https://lnkd.in/eFqu7vr4. #HealthEquity #ClinicalTrials

I really enjoyed last week's "Conversations with Black Pharma" featuring Fitzroy Dawkins, M.D. It was a conversation based on his book “Fighting for Survival: Conquering Cancer and the African American Patient” My main takeaways were: We do not have to automatically view cancer patients as end-stage cases; instead, we should see it as an opportunity to build on our legacy of success in treating cancer patients. I also gained an understanding of why African Americans are cautious regarding clinical trials. This caution stems from the justified grievances of the past, such as the unethical Tuskegee experiments—a period so troubling that even Bill Clinton, as a United States president, offered an apology. However, these dark periods also catalysed great changes beneficial to ALL Americans. Now, all clinical trials require informed consent forms written at an eighth-grade reading level, participation must be voluntary, and patients must receive regular monitoring. Dr. Dawkins also touched on how spirituality and religion can act as barriers for African Americans considering clinical trials. As one of the most spiritual and religious ethnic groups, with a large percentage adhering to the "prosperity doctrine," there is a belief that good deeds yield good outcomes and that prayer can resolve any adversity, including illness, which may be seen as a lack of faith or a divine punishment. Some believe that strong faith corrects ailments and that God is expected to intervene (e.g., in curing cancer). Dr. Dawkins proposed a mindset shift 🌄 where, instead of thinking, "I will pray and it will go away," more African Americans should see medicines as God-given miracles aiding them on the journey to a better life. After this enlightening conversation, I strongly feel that we need more interaction and collaboration between Pharma and faith leaders in minority communities! If you are interested check out the book: https://amzn.eu/d/fCG2Yky #ConversationsWithBlackPharma #ClinicalTrials #DiversityInMedicine #FaithAndMedicine

Racial disparities in healthcare involve using a race-based formula in kidney function tests. This formula, designed to estimate kidney function, has reportedly overestimated the health of approximately 14,000 Black patients seeking transplants. Such a biased approach not only magnifies existing health disparities but also places Black patients at a significantly higher risk despite their already increased likelihood of requiring kidney transplants. Baxter International Inc., under the visionary leadership of Regina Atkins, launched the Black K.A.R.E. (Kidney Awareness Resources and Education) Initiative. This pioneering program aims to enhance the understanding of Chronic Kidney Disease (CKD) within Black communities by focusing on risk factors, complications, treatments, and strategies to mitigate kidney failure or improve outcomes for individuals living with CKD. The initiative addresses the immediate concerns related to racial bias in healthcare and paves the way for more inclusive and equitable health practices. #HealthEquity #KidneyTransplant #RacialBiasInHealthcare #BlackKARE #BaxterInternational https://lnkd.in/gcpWDfWN

"Navigating Genetic Waters: A Black Man's Perspective on Kidney Health and Medication Access"   This Black History Month, the Partnership would like to spotlight Mr. Dirrell Jones, a Texas Kidney Foundation patient advocate and kidney transplant recipient. In his most recent op-ed, Jones shares his personal battle with kidney disease, rooted in a genetic predisposition linked to the APOL1 gene variation, common among individuals of Caribbean and sub-Saharan African descent. Despite leading a healthy lifestyle, Jones was not spared from the disease that had already claimed the lives of 16 family members. In this thoughtful piece, he underscores the need for patient access to vital medications, especially immunosuppressants. "Understanding the APOL1 gene is only part of the equation. The broader issue lies in addressing disparities in healthcare, ensuring that all members of our community have access to the medical resources they need. This brings us to a critical juncture – the importance of patient access to vital medications, particularly immunosuppressants, falling within the six protected classes."   To view Jones' recent op-ed, please visit: https://lnkd.in/eVgR-hEW   To hear Jones speak on his experience, please see our most recent briefing at: https://lnkd.in/eCPPJDMa  

Improved inclusivity in clinical research requires trust, which in turn requires a transparent conversation about the history of injustices in clinical research. “Medical research in the U.S. has a dark history, particularly when it comes to the Black community. This has led to many in communities of color to distrust the institution of medicine. Crosscut investigates what that means for research and treatment, and why representation matters when it comes to clinical studies.” #clinicalresearch #clinicaltrials #diversity #inclusivity

As an ASR III in BMC’s adult hematology-oncology clinic, Peter R. schedules adult patients with cancers and blood disorders for treatments and follow-ups. He also mentors children on the autism spectrum with TEAM (Teens Engaged as Mentors) and was recently selected for Pathways, our leadership acceleration program for employees of color. Today, Pete shares his thoughts on Black History Month. 💭 What does this month mean to you? 🗣️ This is a time to reflect on our history and all the changes past leaders have implemented in the community and the world. For me, it’s also about taking pride not only in being Black but also in who I am as a person. It means staying the course and not changing who you are just because society may see you as someone you are not. 💭 How does your background affect the care you provide? 🗣️ Growing up in a single-parent household in Mattapan gave me a broad understanding of how to take care of people. I went to predominantly white schools through METCO [a program that enrolls Boston students of color in suburban schools], which allowed me to see both sides. I feel like my background allows me to really help by connecting with people from all aspects of life. 💭 Why is it important for BMC to hire diverse staff? 🗣️ When patients of color see someone who looks like them, speaks their language, or can relate to what they may be going through in life, it helps them feel welcome. When a hospital doesn’t feel like such a daunting place, people want to come back and get the care they need to be healthy. My long-term goal is to help make healthcare extremely welcoming and diverse to all individuals seeking quality care. 💭 What do you enjoy most about BMC? 🗣️ Definitely being able to connect with patients, and all the opportunities for employees. The first day of Pathways, I told the facilitator I want to be a leader within the hospital and also outside the hospital with kids who are in tough situations. I want them to know there are so many options and avenues in life other than street violence or any other negative impacts they may face. Being a leader is not just leading at work, but in your community and with the people around you. Black History Month is a time for reflection and celebration of the incredible contributions made by Black people. Black history continues to shape BMC Health System’s ability to close health disparities through our innovative and equitable care.

As Black History Month draws to a close, @Strategygen reflects not only on the remarkable achievements of trailblazers like Dr. Charles Drew but also on the ongoing disparities in healthcare faced by minority, rural, and underserved communities. Drew's pioneering work in blood preservation not only transformed medicine but also challenged racial barriers in the field, paving the way for future generations of Black scientists and healthcare professionals. However, even as we celebrate these strides, we cannot ignore the pressing need for equitable access to healthcare resources, including blood donations. Blacks and other individuals in minority, rural, and underserved urban communities are disproportionately affected by conditions that require blood transfusions, yet they are often underrepresented among blood donors. Let us honor the legacy of Charles Drew by addressing this disparity head-on. Type O blood is often referred to as the "universal donor" because it can be transfused into patients of any blood type, making it indispensable in emergencies when time is of the essence. However, Type O blood is currently in short supply, leaving hospitals and blood banks grappling with the challenge of meeting demand. With accidents, surgeries, and medical emergencies occurring every day, the need for Type O blood donors has never been more urgent. By increasing awareness, promoting diversity in donor pools, and supporting initiatives to eliminate healthcare inequalities, we can ensure that every individual, regardless of race or background, has access to lifesaving blood transfusions when needed most. Let us continue Drew's legacy of activism and compassion by working towards a future where healthcare disparities are a thing of the past. #typeoblood #criticalshortage #beadonor

🎉✨ *Exciting Partnership Announcement!* ✨🎉 I am thrilled to announce a significant new partnership between MTS Research Solutions (MTS SICKLE CELL FOUNDATION INC ) and Randomize Now Research Centers, a crucial step forward in our shared mission to support the Sickle Cell Disease (SCD) community through impactful research and engagement. Representation of Sickle Cell Warriors in clinical research is essential. Historically, they have been underrepresented, leading to gaps in understanding and tailored treatment options. By partnering with Randomize Now Research Centers, we aim to bridge this gap and ensure they have a voice in research. This partnership will: - Enhance Research Participation: Encourage Sickle Cell Warriors' involvement in clinical trials for treatments tailored to their needs. - Improve Patient Outcomes: Discover more effective treatments and enhance the quality of life for those with Sickle Cell Disease. - Raise Awareness: Increase awareness about the importance of clinical research participation. Ways to support us: 1. Share Study Pipelines for Sickle Cell Disease research. 2. Support Community Engagement efforts. 3. Promote Our Partnership to spread awareness. Huge thanks Danielle S. Mitchell for making this connection Black Women In Clinical Research ® Together, we can make a profound impact on the lives of Sickle Cell Warriors and their families. Your continued support is crucial for the success of this initiative. Stay tuned for more updates as our collaboration progresses! #SickleCell #ResearchPartnership #ClinicalTrials #PatientOutcomes #CommunityEngagement #RaiseAwareness

Today, I am highlighting: Herbert Nickens, MD, was the first Director of the Office of Minority Health at the U.S. Department of Health and Human Services (HHS). He set the foundation for promoting improved health among racial and ethnic minority populations across the country. He left the HHS, and moved to the AAMC, where he was the founding Vice President of the AAMC Division of Community and Minority Programs, now known as Diversity Policy and Programs. He led the AAMC's Project 2000 by 3000. which the AAMC launched in 1991 to achieve the goal of enrolling 3,000 students from underrepresented minority groups in U.S. medical schools annually by the year 2000. He also developed a program to mentor and promote the careers of minority academic physicians. For further information on Herbert W. Nickens, MD, click on the link below: https://lnkd.in/gSrHrFSW Join me in attending the 2024 Black Parkinson’s Disease Summit: https://lnkd.in/gPxWW5dg #parkinsonsdisease #yopd #Parkinsonsresources #Parkinsonsawareness  #Neurology  #brainhealth  #health  #healthandwellness  #wellness  #wpc #Parkinsons #BlackwithPD #AfricanAmericanwithPD #clinicaltrials  #pdmovers #parkinsonresearch #blackpd #100blackmen #100blackwomen #blacksororities #blackfraternities #naacp #urbanleague #rainbowpush #blackcaucus #BlackExcellence #SIG-BlackDiaspora #AfricanAmericanwithPD #underservedcommunities #underengaged #PDawareness #BlackwithPD #AfricanAmericanwithPD